CAMELA, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 895
EU - Europa 404
AS - Asia 329
AF - Africa 24
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.655
Nazione #
US - Stati Uniti d'America 887
SG - Singapore 136
IT - Italia 114
HK - Hong Kong 108
DE - Germania 87
RU - Federazione Russa 43
IN - India 42
NL - Olanda 36
FR - Francia 34
CN - Cina 28
CI - Costa d'Avorio 22
GB - Regno Unito 22
UA - Ucraina 15
FI - Finlandia 9
IE - Irlanda 9
SE - Svezia 9
BG - Bulgaria 8
CA - Canada 7
RS - Serbia 4
ID - Indonesia 3
JP - Giappone 3
KR - Corea 3
PL - Polonia 3
RO - Romania 3
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
AM - Armenia 1
AZ - Azerbaigian 1
BE - Belgio 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.655
Città #
Chandler 150
Ashburn 140
Singapore 107
Hong Kong 105
Santa Clara 90
Amsterdam 32
Lawrence 32
Napoli 31
Millbury 26
Naples 21
Seattle 20
Boston 19
Wilmington 19
Washington 17
Des Moines 16
Menlo Park 15
Krefeld 12
Fairfield 11
Houston 10
Los Angeles 9
Milan 9
Pune 9
Woodbridge 9
Sofia 8
Bhubaneswar 5
Helsinki 5
Fremont 4
Kronberg 4
Lappeenranta 4
Redwood City 4
Afragola 3
Bucharest 3
Dallas 3
Dublin 3
Esslingen am Neckar 3
Frankfurt am Main 3
Gangnam-gu 3
Hyderabad 3
Munich 3
Palermo 3
Paris 3
Roccasecca 3
Rottweil 3
San Giuseppe Vesuviano 3
Segrate 3
Tokyo 3
Boardman 2
Changsha 2
Clifton 2
Council Bluffs 2
Edinburgh 2
Lugano 2
Milazzo 2
Nuremberg 2
Paternò 2
Rietheim-Weilheim 2
Rome 2
San Diego 2
Shanghai 2
Studzianki 2
Véry 2
Algiers 1
Augusta 1
Baku 1
Battipaglia 1
Birmingham 1
Bishkek 1
Bordeaux 1
Borås 1
Boulder 1
Brussels 1
Budapest 1
Cambridge 1
Central 1
Chapel Hill 1
Chennai 1
Cologne 1
Cormons 1
Duncan 1
Elora 1
Ferrol 1
Folignano 1
Giugliano in Campania 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Harbin 1
Hutchinson 1
Jakarta 1
Jinan 1
Johannesburg 1
Las Palmas 1
London 1
Magenta 1
Melbourne 1
Montreal 1
Mountain View 1
Mussidan 1
New Orleans 1
New York 1
Totale 1.060
Nome #
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 87
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 81
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 68
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 65
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case 60
A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents 54
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 54
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 45
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 43
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 40
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 38
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 38
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 35
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 35
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 35
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 35
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge 35
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 34
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 33
New frontiers in personalized medicine in psoriasis 33
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study 33
Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study 33
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5" 32
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting 31
A case of erythrodermic psoriasis successfully treated with guselkumab 31
Nail changes as manifestation of systemic disease in COVID‐19 infection 31
Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al 31
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 30
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab 30
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 29
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al 28
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 28
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 27
Letter to the editor regarding article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610." 27
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 27
Teledermatology: a useful tool also after Covid-19 era? 27
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? 26
A case of erythrodermic psoriasis successfully treated with apremilast 26
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 25
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 24
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics 24
Treating psoriasis in the elderly: biologics and small molecules 22
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 22
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al 19
Towards Personalized Medicine in Psoriasis: Current Progress 19
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 17
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study" 17
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings 15
Paradoxical reactions to biologicals for psoriasis 15
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study 15
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 14
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 14
Giant basal cell carcinoma of the vulva successfully treated with Sonidegib 10
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 9
Totale 1.756
Categoria #
all - tutte 9.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 1 1 2 10 6
2020/2021151 2 4 2 1 7 10 2 45 62 8 8 0
2021/2022277 1 7 0 14 15 6 8 17 63 41 24 81
2022/2023454 37 35 15 17 39 56 49 64 65 36 32 9
2023/2024397 24 46 33 40 38 88 6 51 2 8 48 13
2024/2025457 74 24 7 14 52 108 153 25 0 0 0 0
Totale 1.756